Biotechnology company using physics-based AI to map intrinsically disordered protein regions and identify novel drug targets, including targets in proteins that have been difficult to drug, to accelerate early-stage drug discovery
Biotechnology company using physics-based AI to map intrinsically disordered protein regions and identify novel drug targets, including targets in proteins that have been difficult to drug, to accelerate early-stage drug discovery.